SignalXSignalX

SEM SELECT MEDICAL HOLDINGS CORP

8-K Current Report
Filed: March 3, 2026
Health Care
Services-Hospitals
SELECT MEDICAL HOLDINGS CORP Overview

SELECT MEDICAL HOLDINGS CORP (SEM) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

  • Item 1.01: Entry into a Material Definitive Agreement
  • Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 1.01 · Entry into a Material Definitive Agreement

  • • Merger Consideration: $16.50/share cash — SEM shareholders receive fixed takeout price, shares to be delisted from NYSE upon close
  • • Buyer is Stallion Intermediate Corp, financed by private equity firm WCAS XIV, L.P. (Welsh, Carson, Anderson & Stowe) via equity + debt commitment letters
+3 more insights

Item 7.01 · Regulation FD Disclosure

  • • SEM undergoing proposed go-private acquisition — company filing Schedule 14A proxy and Schedule 13E-3, signaling a take-private or buyout structure
  • • Stockholder vote required to approve merger — failure to obtain approval is an explicit deal-closing risk
+3 more insights

Get deeper insights on SELECT MEDICAL HOLDINGS CORP

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.